We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUYA
251
Huya Inc
HUYA
$551M
$73.5K 0.03%
22,273
-31,032
-58% -$114K
IVVD icon
252
Invivyd
IVVD
$219M
$72.8K 0.03%
55,990
-12,853
-19% -$23.6K
VIR icon
253
CALL
Vir Biotechnology
VIR
$1.59B
$68.5K 0.03%
225
-13
-5% -$104
PEPG icon
254
PepGen
PEPG
$156M
$67.5K 0.03%
+38,152
New +$214K
YSG
255
Yatsen Holding
YSG
$335M
$62.1K 0.02%
20,151
+9,819
+95% +$39.5K
PGEN icon
256
Precigen
PGEN
$1.76B
$54.1K 0.02%
+13,978
New +$57.4K
SLS icon
257
CALL
SELLAS Life Sciences
SLS
$2.59B
$52.7K 0.02%
758
-387
-34% -$1.73K
KKR icon
258
CALL
KKR & Co
KKR
$90.6B
$50.4K 0.02%
+140
New +$14.8K
UPB
259
Upstream Bio Inc
UPB
$381M
$49.5K 0.02%
5,495
-3,412
-38% -$61.4K
VYGR icon
260
CALL
Voyager Therapeutics
VYGR
$192M
$48.5K 0.02%
+379
New +$1.49K
CMPS
261
Compass Pathways
CMPS
$1.67B
$44.6K 0.02%
8,060
+2,577
+47% +$17.3K
MNPR icon
262
Monopar Therapeutics
MNPR
$744M
$42.9K 0.02%
+783
New +$47.3K
GPCR icon
263
PUT
Structure Therapeutics
GPCR
$3.45B
$42.6K 0.02%
+323
New +$22.1K
VRTX icon
264
CALL
Vertex Pharmaceuticals
VRTX
$123B
$41.2K 0.02%
236
– –
PASG icon
265
Passage Bio
PASG
$15.5M
$38.9K 0.01%
+4,955
New +$51.3K
UPST icon
266
CALL
Upstart Holdings
UPST
$2.82B
$36K 0.01%
+188
New +$6.61K
BE icon
267
Bloom Energy
BE
$61.1B
$33.2K 0.01%
245
-1,152
-82% -$169K
RKT icon
268
CALL
Rocket Companies
RKT
$41.1B
$30.9K 0.01%
326
+236
+262% +$4.29K
IOVA icon
269
CALL
Iovance Biotherapeutics
IOVA
$2.23B
$30K 0.01%
+758
New +$2.42K
TLPH icon
270
Talphera
TLPH
$68.5M
$29.1K 0.01%
38,968
+2,338
+6% +$2.12K
RCKT icon
271
Rocket Pharmaceuticals
RCKT
$376M
$27.7K 0.01%
+7,731
New +$30.7K
ASND icon
272
CALL
Ascendis Pharma A/S
ASND
$17.1B
$27.1K 0.01%
+237
New +$53.1K
LYEL icon
273
PUT
Lyell Immunopharma
LYEL
$326M
$26.9K 0.01%
10
– –
PRTC
274
DELISTED
PureTech Health
PRTC
$26.1K 0.01%
1,759
– –
CELC icon
275
CALL
Celcuity
CELC
$4.31B
$19.4K 0.01%
+45
New +$4.91K
9 10
11
12 13

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.